$46.76 +0.17 (0.37%) Southern Co - New York Stock Exchange, Inc.

Dec. 2, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 46.76
Trade Time: Dec 02 04:00 PM Eastern Daylight Time
Change: +0.17 (0.37%)
Prev Close: 46.59
Open: 46.92
Bid: 46.73
Ask: 46.80
  1. Dividend Growth Stocks For A Successful Retirement Plan

    TalkMarkets | Nov. 17, 2016 | 13:55PM EST
  2. Daily Update: Dallas Fed Down 22 Straight Months

    TalkMarkets | Oct. 31, 2016 | 13:00PM EST
  3. Which Is The Better Valuation Metric? The P/E Ratio Or The PEG Ratio: Part 1

    TalkMarkets | Oct. 29, 2016 | 16:01PM EST
  4. Recent Stock Purchase October 2016

    TalkMarkets | Oct. 21, 2016 | 14:12PM EST
  5. A Guide To Conservative Income Producing Option Strategies For Dividend Stocks

    TalkMarkets | Oct. 13, 2016 | 13:01PM EST
  6. Utilities Look Towards Growth Outside Their Comfort Zones

    Dividend.com | Oct. 3, 2016 | 09:00AM EST
  7. How Will Utilities Be Affected If Donald Trump Wins

    Dividend.com | Sep. 9, 2016 | 11:00AM EST
  8. Southern Company Leads 52 Stocks Going Ex-Dividend Next Week

    Dividend.com | Aug. 4, 2016 | 07:00AM EST
  9. The Top 3 Utility Stock ETFs for High Dividend Yields (XLU, IDU, VPU)

    Dividend.com | Aug. 2, 2016 | 08:09AM EST
  10. Nasdaq Thrusts 1%; 6 Stocks That Are Breaking Out Now

    Investors Business Daily | Jul. 20, 2016 | 13:23PM EST
  11. Weekly CFO Sells Highlights

    GuruFocus | Jul. 12, 2016 | 11:00AM EST
  12. Southern Power And Turner Renewable Energy Announce Joint Acquisition Of A 20-Megawatt Solar Facility

    Benzinga | Feb. 16, 2016 | 08:03AM EST
  13. Weekly CEO Sells Highlight: Monolithic Power Systems, Five Prime Therapeutics, Nektar Therapeutics

    GuruFocus | Feb. 15, 2016 | 12:58PM EST
  14. UPDATE: Southern Co Subsidiary, Turner Renewable Energy Acquire Calipatria Solar Facility in CA; Terms Not Disclosed

    Benzinga | Feb. 15, 2016 | 09:06AM EST
  15. Weekly CEO Sales Highlight: Monolithic Power Systems, Five Prime Therapeutics, Nektar Therapeutics

    GuruFocus | Feb. 14, 2016 | 14:30PM EST
Trading Center